Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Lumos Diagnostics Holdings Ltd

LDX.AX ✓ COMPLIANT ☆ Track — members

ASX · Healthcare · Medical Equipment, Supplies & Distribution ·

Australia Micro Cap Analyst: BUY

Last Close

$0.08

▲ +8.25%

Market Cap $71.44M · Vol 841.72K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$71.44M

Micro Cap

Div Yield

N/A

EPS Growth

-134.51%

YoY

RSI (14)

39.13

Momentum

Beta

1.91

vs Market

52W High

$0.24

66.95% below

52W Low

$0.05

42.21% above

Volume

841.72K

Avg 1.10M

P/B

3.00

Price-to-book

ROE

N/A

Return on equity

Free Float

79.82%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Lumos Diagnostics Holdings Ltd (LDX.AX) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does LDX.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+5.00%

-19.23%

+0.00%

-61.82%

YTD

-63.16%

-12.50%

+45.27%

-90.21%

Financials & Valuation

TTM · Annual

Total Revenue	$13.19M
Net Income	$-4,952,000.00
Revenue Growth (YoY)	+16.05%
Gross Margin	40.82%
Operating Margin	-66.33%
Net Profit Margin	-37.54%
ROE	N/A
ROA · ROIC	-16.09% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	4.48
P/B	3.00
P/FCF	N/A
EPS Growth	-134.51%
Outstanding Shares	945.12M

Technical Indicators

50-Day SMA	$0.08
200-Day SMA	$0.13
RSI (14)	39.13
Beta	1.91
52-Week High	$0.24
52-Week Low	$0.05

Volume Today	841.72K
Avg Daily Volume (30D)	1.10M
Relative Volume	0.76x
Volatility (10D)	69.12
Volatility (30D)	96.12
Free Float	79.82%

Analyst Consensus

BUY

Current Price $0.08

Mean Target $0.17

52W Low$0.05 52W High$0.24

Current

Target

$0.05 $0.24

Current Analyst target

+130.56% upside potential · 1 analysts

Identifiers

ExchangeASX

FIGIBBG00P9HMYP1

ISINAU0000157091

CountryAustralia

Sub-IndustryLaboratory Diagnostic & Testing Substances

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

GH Guardant Health Inc +0.23% BIM.PA Biomerieux SA -2.24% TXG 10X Genomics Inc -0.90% CAI Caris Life Sciences Inc -0.99% LNTH Lantheus Holdings Inc -0.01%

Company Profile

Lumos Diagnostics Holdings Limited is an Australia-based company specializes in point-of-care (POC) diagnostic test technology to help healthcare professionals diagnose and manage medical conditions. The Company offers customized assay development and manufacturing services for POC tests and digital reader platforms. It also directly develops, manufactures, and commercializes Lumos-branded POC tests that target infectious and inflammatory diseases. Its Products offering is based on developing and commercializing its own suite of POC diagnostic products which are primarily focused on the diagnosis and management of infectious diseases. These include FebriDx, a POC test for detecting and differentiating viral and bacterial respiratory infections, and ViraDx, a rapid point-of-care diagnostic product that simultaneously tests for acute respiratory infections caused by the COVID-19, influenza A, and influenza B viruses. It manages the full development program for POC assays.